Subsequently, association of TG2 overexpression with aggressive form of the disease was reported for pancreatic [30,117], glioblastoma [118], melanoma [32], lung [34], ovarian [33,119], colon [120] cancers and most recently, RCC [29,35,36]. This evidence concerns the gene TGM2 and cancer.